Advanced search
Start date
Betweenand


Anti-inflammatory and antioxidant activities of Citrus aurantifolia (Christm.) Swingle essential oil in dystrophic muscle cells: implication of the PGC-1α pathway

Full text
Author(s):
Moraes, Fernanda dos Santos Rapucci ; Moraes, Luis Henrique Rapucci ; Macedo, Aline Barbosa ; Valduga, Amanda Harduim ; Mizobuti, Daniela Sayuri ; da Rocha, Guilherme Luiz ; da Silva, Heloina Nathallie Mariano ; Salvador, Marcos Jose ; Minatel, Elaine
Total Authors: 9
Document type: Journal article
Source: Journal of Essential Oil Bearing Plants; v. 27, n. 1, p. 13-pg., 2024-01-06.
Abstract

The commercial essential oil obtained from the steam distillation of cold-pressed oil from Citrus aurantifolia (Christm.) Swingle fruits (OCA), after chemical characterization by gas chromatography-mass spectrometry (GC-MS), was investigated for antioxidant and anti-inflammatory activities and related signaling pathways in dystrophic muscle cells. The chemical composition of OCA showed 24 compounds with a predominance of monoterpenes, such as limonene (42.6%), cymene (11.8%), alpha-terpineol (11.8%), terpinolene (5.3%) and gamma-terpinene (4.6%). DPHH and ORAC assays showed a significant antioxidant activity of OCA. Because the OCA is rich in limonene, it exhibited marked anti-inflammatory (as indicated by the reduction of TNF- alpha and NF-kappa B levels) and antioxidant effects (as indicated by the reduction of 4-HNE-protein adducts, SOD-2, GSR and H2O2 levels) on dystrophic muscle cells. These effects appear to be mediated through the activation of PGC-1 alpha pathway. Therefore, OCA can be considered a promising bioactive for therapeutic applications in dystrophinopathies. (AU)

FAPESP's process: 12/09101-1 - Investigation of treatment with 24-epibrassinolide in plant development, profile of volatile constituents and biological activities of essential oils from Cymbopogon citratus, Cymbopogon flexuosus and Mentha pulegium
Grantee:Marcos José Salvador
Support Opportunities: Regular Research Grants
FAPESP's process: 21/09693-5 - Use of microbiome technologies and bioassays for the search for new bioactive compounds in plants and symbionts: implications for metabolic responses, molecular diversity and bioactivity
Grantee:Marcos José Salvador
Support Opportunities: BIOTA-FAPESP Program - Regular Research Grants
FAPESP's process: 17/01638-0 - TEMPOL: POTENTIAL ANTIOXIDANT THERAPY FOR DYSTROPHIC MUSCULAR FIBERS
Grantee:Elaine Minatel
Support Opportunities: Regular Research Grants
FAPESP's process: 10/01087-4 - In vivo and in vitro treatment, with N-acetylcistein and Deferoxamin in dystrophic mouse
Grantee:Luis Henrique Rapucci Moraes
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 13/17732-4 - In vivo and in vitro effect of the antiinflammatory and antioxidant on dystrophic muscle fibers of Mdx mice
Grantee:Elaine Minatel
Support Opportunities: Regular Research Grants
FAPESP's process: 06/06079-4 - Search of antioxidants and antimicrobials in Gomphreneae tribe species
Grantee:Marcos José Salvador
Support Opportunities: Regular Research Grants
FAPESP's process: 15/03726-8 - Integrated chemical and biological study in the search for bioactive substances in plants* and development of analytical procedures. *(Amaranthaceae, Gesneriaceae, Myrtaceae e Annonaceae)
Grantee:Marcos José Salvador
Support Opportunities: Regular Research Grants
FAPESP's process: 11/02474-4 - Treatment in vivo and in vitro with calcium blocker and antioxidant in mdx mice
Grantee:Elaine Minatel
Support Opportunities: Regular Research Grants
FAPESP's process: 20/09733-4 - Effect of photobiomodulation and antioxidant therapies on cellular, tissue, molecular and biochemical events on dystrophic muscle fibers in Mdx mice
Grantee:Elaine Minatel
Support Opportunities: Regular Research Grants